静脉血栓栓塞-话题@MedSci

#静脉血栓栓塞#

15篇内容 | 3745人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1241718, encodeId=2c181241e18b8, content=<a href='/topic/show?id=f5f610462e09' target=_blank style='color:#2F92EE;'>#Milvexian#</a>预防<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>，这是一种新型的<a href='/topic/show?id=8516552389b' target=_blank style='color:#2F92EE;'>#抗凝药#</a>物，未来前景可期！, objectTitle=NEJM：Milvexian用于预防静脉血栓栓塞, objectType=article, longId=221432, objectId=30622214323d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021122/1638403448315_1739456.jpg, objectUrl=/article/show_article.do?id=30622214323d, replyNumber=0, likeNumber=162, createdTime=2022-08-29, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30622214323d, moduleTitle=NEJM：Milvexian用于预防静脉血栓栓塞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30622214323d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241571, encodeId=105612415e134, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=J Thromb Haemost：COVID-19疫苗接种后静脉血栓栓塞的风险, objectType=article, longId=724198, objectId=82ace2419885, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220413/1649820895319_1739456.jpg, objectUrl=/article/show_article.do?id=82ace2419885, replyNumber=0, likeNumber=137, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82ace2419885, moduleTitle=J Thromb Haemost：COVID-19疫苗接种后静脉血栓栓塞的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82ace2419885)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241570, encodeId=293612415e026, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=JAHA：静脉血栓栓塞的家族性分离, objectType=article, longId=292187, objectId=4ed129218ef5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20211217/1639750285474_1739456.jpg, objectUrl=/article/show_article.do?id=4ed129218ef5, replyNumber=0, likeNumber=118, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ed129218ef5, moduleTitle=JAHA：静脉血栓栓塞的家族性分离, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ed129218ef5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241569, encodeId=e44b12415695e, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a><a href='/topic/show?id=3c531016e571' target=_blank style='color:#2F92EE;'>#骨折#</a>, objectTitle=2021年版《亚太膝关节和髋关节置换术和髋部骨折手术静脉血栓栓塞共识：静脉血栓栓塞症的药物预防》解读, objectType=guider, longId=16895, objectId=367a71c002a25640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=367a71c002a25640, replyNumber=0, likeNumber=164, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=367a71c002a25640, moduleTitle=2021年版《亚太膝关节和髋关节置换术和髋部骨折手术静脉血栓栓塞共识：静脉血栓栓塞症的药物预防》解读, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=367a71c002a25640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241568, encodeId=94681241568df, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a><a href='/topic/show?id=ea866e8110d' target=_blank style='color:#2F92EE;'>#物理治疗#</a>, objectTitle=2022 APTA循证临床实践指南：物理治疗师在具有静脉血栓栓塞风险或被诊断为静脉血栓栓塞患者的管理中的作用, objectType=guider, longId=17931, objectId=b638a1c002529254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=b638a1c002529254, replyNumber=0, likeNumber=144, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b638a1c002529254, moduleTitle=2022 APTA循证临床实践指南：物理治疗师在具有静脉血栓栓塞风险或被诊断为静脉血栓栓塞患者的管理中的作用, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=b638a1c002529254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241567, encodeId=5759124156e31, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=静脉血栓栓塞症国内外指南解读, objectType=guider, longId=16811, objectId=865af1c002a1e257, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=865af1c002a1e257, replyNumber=0, likeNumber=159, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=865af1c002a1e257, moduleTitle=静脉血栓栓塞症国内外指南解读, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=865af1c002a1e257)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241566, encodeId=8360124156664, content=<a href='/topic/show?id=4e7386e5810' target=_blank style='color:#2F92EE;'>#艾多沙班#</a>、<a href='/topic/show?id=decb3226811' target=_blank style='color:#2F92EE;'>#利伐沙班#</a>和<a href='/topic/show?id=95089e7452f' target=_blank style='color:#2F92EE;'>#阿哌沙班#</a>在<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a><a href='/topic/show?id=23c58911686' target=_blank style='color:#2F92EE;'>#血栓栓塞#</a>, objectTitle=J Thromb Haemost：艾多沙班、利伐沙班和阿哌沙班在静脉血栓栓塞患者中的疗效和安全性比较, objectType=article, longId=730707, objectId=45e3e3070798, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220627/1656343907354_1739456.jpg, objectUrl=/article/show_article.do?id=45e3e3070798, replyNumber=0, likeNumber=0, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45e3e3070798, moduleTitle=J Thromb Haemost：艾多沙班、利伐沙班和阿哌沙班在静脉血栓栓塞患者中的疗效和安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45e3e3070798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=916132, encodeId=ab6b91613292, content=<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a>, objectTitle=Crit Care：危重患者静脉血栓栓塞发生率、预后因素和结局, objectType=article, longId=205694, objectId=d1cd20569440, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021113/1610496706393_1739456.jpg, objectUrl=/article/show_article.do?id=d1cd20569440, replyNumber=0, likeNumber=223, createdTime=2021-01-13, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1cd20569440, moduleTitle=Crit Care：危重患者静脉血栓栓塞发生率、预后因素和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1cd20569440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=904243, encodeId=4b7a90424351, content=<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌症#</a>患者的<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#静脉血栓栓塞#</a><a href='/topic/show?id=4a481855350' target=_blank style='color:#2F92EE;'>#VTE#</a>风险，这可能有多种原因，其一现在的治疗多是免疫治疗和靶向治疗，其二，患者的生存期延长，<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>患者多是<a href='/topic/show?id=ca06102195ec' target=_blank style='color:#2F92EE;'>#高凝状态#</a>，容易并发血栓。同时，如果适当的<a href='/topic/show?id=606b55e4466' target=_blank style='color:#2F92EE;'>#抗血小板#</a>和<a href='/topic/show?id=353b55219b8' target=_blank style='color:#2F92EE;'>#抗凝#</a>治疗，可能会有利于改善<a href='/topic/show?id=f0838291817' target=_blank style='color:#2F92EE;'>#肿瘤微环境#</a>，有利于治疗。, objectTitle=Blood：1997年-2017年癌症患者的静脉血栓栓塞风险变化, objectType=article, longId=203916, objectId=4d2220391612, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/type2diabetes-s18-plaque-in-artery.jpg, objectUrl=/article/show_article.do?id=4d2220391612, replyNumber=0, likeNumber=441, createdTime=2020-12-02, rootId=0, userName=lifefamily@163, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d2220391612, moduleTitle=Blood：1997年-2017年癌症患者的静脉血栓栓塞风险变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d2220391612)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

静脉血栓栓塞

2020-05-29

循证小兵 (审核中...)

前往app查看评论内容

#Milvexian#预防#静脉血栓栓塞#，这是一种新型的#抗凝药#物，未来前景可期！

NEJM：Milvexian用于预防静脉血栓栓塞

2022-08-29

循证小兵 (审核中...)

前往app查看评论内容

#静脉血栓栓塞#

J Thromb Haemost：COVID-19疫苗接种后静脉血栓栓塞的风险

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#静脉血栓栓塞#

JAHA：静脉血栓栓塞的家族性分离

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#静脉血栓栓塞##骨折#

2021年版《亚太膝关节和髋关节置换术和髋部骨折手术静脉血栓栓塞共识：静脉血栓栓塞症的药物预防》解读

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#静脉血栓栓塞##物理治疗#

2022 APTA循证临床实践指南：物理治疗师在具有静脉血栓栓塞风险或被诊断为静脉血栓栓塞患者的管理中的作用

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#静脉血栓栓塞#

静脉血栓栓塞症国内外指南解读

2022-08-28

循证小兵 (审核中...)

前往app查看评论内容

#艾多沙班#、#利伐沙班#和#阿哌沙班#在#静脉血栓栓塞##血栓栓塞#

J Thromb Haemost：艾多沙班、利伐沙班和阿哌沙班在静脉血栓栓塞患者中的疗效和安全性比较

2022-08-28

zb1235672 (审核中...)

前往app查看评论内容

#静脉血栓栓塞#

Crit Care：危重患者静脉血栓栓塞发生率、预后因素和结局

2021-01-13

lifefamily@163 (审核中...)

前往app查看评论内容

#癌症#患者的#静脉血栓栓塞##VTE#风险，这可能有多种原因，其一现在的治疗多是免疫治疗和靶向治疗，其二，患者的生存期延长，#肿瘤#患者多是#高凝状态#，容易并发血栓。同时，如果适当的#抗血小板#和#抗凝#治疗，可能会有利于改善#肿瘤微环境#，有利于治疗。

Blood：1997年-2017年癌症患者的静脉血栓栓塞风险变化

2020-12-02

科室
- - 订阅+
  - 更多科室
工具
服务